The OJC Episode 24: PRODIGE 7, CRC Mortality, Treatment Delays, Surveillance Mammography, Late Mortality, Tweetations and Saddle Sores!

Send us a text

The Oncology Journal Club - Delivering Oncology News Differently
The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 24 in our series The Oncology Journal Club.

Hans Prenen gets us started with the PRODIGE 7 trial and a comparative study on colorectal cancer mortality in young adults which interestingly is rising USA, Canada and Australia, but not in Europe and Asia.

Eva Segelov gives us insight into delays with the development of a model to estimate the association between delay in cancer treatment and local tumor control and the risk of metastases and sets Craig Underhill a homework task on fractals.

We’ve given Craig a break from main papers this week after last week’s epic episode on ASCO GI which I highly recommend you listen to, if you’ve not already.

Our Quick Bites are a must listen too this week... everyone has something fascinating to share. Where else will you hear about colorectal cancer cells entering a diapause-like DTP state – aka hibernation, tweetations and the public disclosure of identifiable patient information by health professionals on twitter, surveillance mammography for older patients, why Albury is called Smallbury, an Australian study on late mortality in people with cancer and saddle sores among female competitive cyclists.

With the usual top quality banter, papers you won’t hear of anywhere else and expert analysis from our Hosts, you are in for another great episode of The Oncology Journal Club!

Full bios and the list of all papers discussed are available on our website.For the latest oncology news visit www.oncologynews.com.au and for regular oncology updates for healthcare professionals, subscribe for free to get the weekly The Oncology Newsletter.
The Oncology Podcast - An Australian Oncology Perspective